Other HSP90 inhibitors, AUY-922 and 17-AAG, were previously shown to block TGF-β signaling in either a model of nitrogen-mustard induced chronic lung injury or in in vitro studies on cultured fibroblast [12,29]. Here, TGFB1 is linked to injury.